Broad spectrum of small molecules, drugs, toxins, proteins, and metabolites

The term Broad spectrum of small molecules, drugs, toxins, proteins, and metabolites is a descriptive classification rather than a specific, targetable biological molecule or receptor. In pharmacological literature, this phrase is typically used to describe the substrate range of polyspecific proteins, such as the ATP-binding cassette (ABC) transporters or the Cytochrome P450 (CYP) enzyme family (Source: NCBI, StatPearls). For instance, P-glycoprotein (ABCB1) is a well-documented transporter that recognizes and exports a diverse array of hydrophobic small molecules, including various chemotherapeutic agents and environmental toxins (Source: PubMed). Because the term encompasses a vast and heterogeneous group of substances rather than a single gene product, it cannot be classified as a discrete therapeutic target. Consequently, it does not possess a singular mechanism of action, specific disease role, or defined safety profile suitable for drug development analysis. This entry is considered incorrect for the purposes of target identification due to its lack of molecular specificity.